Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
Applied Optics|February 3, 2016
Multiwavelength interferometry system for the Orion laser facilityS Patankar, E T Gumbrell, T S Robinson, et al.The New England Journal of Medicine|March 3, 2006
Natalizumab plus interferon beta-1a for relapsing multiple sclerosisRichard A Rudick, William H Stuart, Peter A Calabresi, et al.Journal of the Neurological Sciences|March 19, 2010
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosisErnst-Wilhelm Radue, William H Stuart, Peter A Calabresi, et al.Molecular Cancer Therapeutics|February 28, 2018
EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell TumorsKenneth S Chen, Nicholas J Fustino, Abhay A Shukla, et al.The Review of Scientific Instruments|November 29, 2014
Monochromatic radiography of high energy density physics experiments on the MAGPIE generatorG N Hall, G C Burdiak, L Suttle, et al.Neurology|September 10, 2003
The utility of MRI in suspected MS [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyE M Frohman, D S Goodin, P A Calabresi, et al.Journal of Neurology|March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINELMichael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.Neurology|November 26, 2003
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional CompositeL J Balcer, M L Baier, J A Cohen, et al.Neurology|September 1, 2007
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINELP A Calabresi, G Giovannoni, C Confavreux, et al.Annals of Neurology|August 19, 2007
Health-related quality of life in multiple sclerosis: effects of natalizumabRichard A Rudick, Deborah Miller, Steve Hass, et al.Pageof 13